General Archive
-
PACE: A £30 million collaborative initiative to tackle antimicrobial resistance
PACE: A £30 million collaborative initiative to tackle antimicrobial resistance We have partnered with Innovate UK and Medicines Discovery Catapult to…
-
News releases
Global AMR challenge receives a £5m boost to drive diagnostics innovation
PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its second funding round with up to £5 million available to support…
-
News releases
LifeArc becomes founding partner of new Fleming Initiative to tackle global threat of antimicrobial resistance
LifeArc has joined the Fleming Initiative as a founding partner alongside Cepheid and Optum, contributing to the initiative reaching a…
-
News releases
LifeArc announces research funding boost to address dengue fever amid growing global health threat
Three new projects, aimed at improving understanding of dengue and preventing the spread of viral disease, have been launched today…
-
News releases
LifeArc co-funds a new blood test that could prevent sudden child deaths caused by hereditary heart condition
A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at…
-
News releases
Britain’s largest health research programme, Our Future Health, forms new £10m partnership with LifeArc
LifeArc has become a funding charity partner of Britain’s largest health research programme, Our Future Health through making a £10m…
-
News releases
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR)
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR), which was published today, highlighting the desperate need…
-
Grand Challenges African Drug Discovery Accelerator programme
Supporting drug discovery projects in sub-Saharan Africa with the Grand Challenges African Drug Discovery Accelerator programme In collaboration with the…
-
FIND
Helping eliminate visceral leishmaniasis in Kenya with FIND We have partnered with the not-for-profit organisation, FIND, to help eliminate visceral…
-
ReACT Africa
Tackling drug-resistant infections with ReACT Africa In partnership with ReAct (Action on Antibiotic Resistance) Africa, we have launched ASPIRE, a…
-
News releases
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
A new £6.2m healthcare project has begun in Kenya to advance elimination of visceral leishmaniasis, a deadly parasitic disease found…